XM does not provide services to residents of the United States of America.

Norway's Equinor scraps plans to export blue hydrogen to Germany



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Norway's Equinor scraps plans to export blue hydrogen to Germany</title></head><body>

OSLO, Sept 20 (Reuters) -Norway's Equinor EQNR.OL has decided to scrap plans to export so-called blue hydrogen to Germany because it is too expensive and there is insufficient demand, a spokesperson for the energy company said on Friday.

In January 2022, Equinor and Germany's RWE RWEG.DE signed a memorandum of understanding to build a hydrogen supply chain for German power plants to help reduce emissions.

The plans included producing hydrogen from natural gas in combination with carbon capture and storage (CCS) - known as blue hydrogen - in Norway and exporting it to hydrogen-ready gas power plants in Germany via the world's first offshore hydrogen pipeline.

"The hydrogen pipeline hasn't proved to be viable. That also implies that hydrogen production plans are also put aside," Equinor's spokesperson Magnus Frantzen Eidsvold told Reuters.

"We have decided to discontinue this early phase project," he added.

RWE could not immediately be reached for comment.

Last year, Equinor CEO Anders Opedal told Reuters the cost of the total supply chain could run into the "tens of billion euros", while the pipeline alone would cost some 3 billion euros ($3.35 billion).

Eidsvold said Equinor also couldn't continue maturing the projects without firm long-term commitments from European buyers to import hydrogen.

"We are not able to make this kind of investments when we don't have long-term agreements and the markets in place," Eidsvold said.

Plans to develop hydrogen-ready gas power plants in Germany with RWE will go ahead but hydrogen for those plans will be procured on the continent, not exported from Norway, Eidsvold said.

Equinor will continue other early phase hydrogen projects, such as in the UK and the Netherlands, as well, he added.



($1 = 0.8955 euros)



Reporting by Nerijus Adomaitis; Editing by Susan Fenton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.